Validea's Leading Consumer Discretionary Stocks According to Joel Greenblatt - September 14, 2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 15 2025
0mins
Should l Buy BBWI?
Source: NASDAQ.COM
Top Rated Consumer Discretionary Stocks: The article highlights top-rated Consumer Discretionary stocks according to Validea's Earnings Yield Investor model, which is based on Joel Greenblatt's strategy focusing on high return on capital and earnings yields.
Company Profiles: It provides detailed descriptions and ratings for several companies, including Bath & Body Works (100% rating), QuantaSing Group (100% rating), Abercrombie & Fitch (90% rating), Best Buy (70% rating), and TopBuild Corp (60% rating), indicating their performance and market positioning.
Investment Strategy: The ratings are based on the companies' underlying fundamentals and stock valuations, with scores above 80% indicating interest and scores above 90% indicating strong interest in the stocks.
About Joel Greenblatt and Validea: The article mentions Joel Greenblatt's successful investment strategy outlined in his book "The Little Book That Beats The Market" and introduces Validea as an investment research service that follows the strategies of renowned investors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BBWI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BBWI
Wall Street analysts forecast BBWI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBWI is 20.14 USD with a low forecast of 15.00 USD and a high forecast of 26.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
4 Buy
10 Hold
0 Sell
Moderate Buy
Current: 22.240
Low
15.00
Averages
20.14
High
26.00
Current: 22.240
Low
15.00
Averages
20.14
High
26.00
About BBWI
Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Class Action Lawsuit Filed Against Bath & Body Works, Inc.
- Lawsuit Background: Bath & Body Works, Inc. (NYSE: BBWI) is facing a class action lawsuit for alleged violations of federal securities laws, targeting the company and its officers on behalf of investors who purchased securities between June 4, 2024, and November 19, 2025.
- Allegations Details: The complaint alleges that throughout the class period, defendants made materially false and misleading statements while failing to disclose adverse facts about the company's business and prospects, misleading investors regarding its financial health.
- Financial Guidance Missteps: The lawsuit claims that the company's strategy of pursuing
See More
Class Action Notice for Bath & Body Works Securities
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the Class Period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm Advantages: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its successful track record and resource advantages, urging investors to select experienced legal counsel wisely.
- Investor Action Recommendations: Investors can visit Rosen Law Firm's website or call the toll-free number for more information on how to participate in the lawsuit, ensuring they have appropriate legal representation in the class action.
See More
Multiple Companies Face Class Action Lawsuits
- Varonis Systems Lawsuit: During the class period from February 4, 2025, to October 28, 2025, Varonis is accused of failing to sustain its annual recurring revenue growth, which has severely undermined investor confidence in the company's prospects, with a lead plaintiff deadline set for March 9, 2026.
- Ardent Health Allegations: Ardent Health faces accusations from July 18, 2024, to November 12, 2025, of inaccurately assessing the collectability of accounts receivable, leading to significant misrepresentation of its financial health, with investors required to act by March 9, 2026.
- CoreWeave Risk Disclosure: CoreWeave is alleged to have overstated its ability to meet customer demand during the period from March 28, 2025, to December 15, 2025, failing to adequately disclose the risks associated with reliance on a single third-party data center, which could materially impact revenue, with a lead plaintiff deadline of March 13, 2026.
- Bath & Body Works Financial Misrepresentation: Bath & Body Works is accused of failing to meet its financial guidance during the period from June 4, 2024, to November 19, 2025, with its brand collaboration strategy not effectively growing its customer base, requiring investor action by March 16, 2026.
See More
Class Action Filed Against Bath & Body Works for Securities Fraud
- Class Action Initiated: Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against Bath & Body Works, Inc., concerning investor losses from June 4, 2024, to November 19, 2025, highlighting serious issues regarding the company's financial transparency.
- Investor Loss Claims: The lawsuit seeks recovery of investment losses for affected investors under federal securities laws, indicating significant misstatements about the company's operations and prospects, which may lead to a decline in investor confidence.
- Financial Guidance Errors: The complaint alleges that Bath & Body Works failed to disclose that its strategy of pursuing “adjacencies, collaborations, and promotions” was not effectively growing its customer base, resulting in the company being unlikely to meet its previously issued financial guidance, potentially impacting future performance.
- Lead Plaintiff Process: Investors have until March 16, 2026, to apply to be appointed as lead plaintiffs in the class action, representing all affected investors in the litigation, underscoring the importance of legal processes in protecting investor rights.
See More
Faruqi & Faruqi Investigates Bath & Body Works for Securities Claims
- Legal Investigation Launched: Faruq & Faruq LLP is investigating Bath & Body Works for potential claims related to securities purchased between June 4, 2024, and November 19, 2025, which may affect investors' legal rights.
- Investor Contact Information: Affected investors are encouraged to contact Faruq & Faruq partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal options regarding the situation.
- Class Action Deadline: The firm reminds investors that March 16, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action filed against Bath & Body Works, emphasizing the importance of timely action.
- Potential Claim Risks: This investigation may lead to claims against Bath & Body Works, highlighting potential risks under securities law, which investors need to monitor closely to ensure their investment safety.
See More
Class Action Lawsuit Reminder Against Bath & Body Works, Inc.
- Class Action Notice: The Schall Law Firm reminds investors of a class action lawsuit against Bath & Body Works, Inc. (NYSE:BBWI) for violations of §§10(b) and 20(a) of the Securities Exchange Act, with a deadline for participation set for March 16, 2026.
- Investor Losses: Investors who purchased the company's securities between June 4, 2024, and November 19, 2025, suffered losses due to the company's false and misleading statements, indicating a failure to effectively grow its customer base and net sales.
- Market Reaction: As the market learned the truth about Bath & Body Works' financial situation, investors faced damages, reflecting the company's failure in brand collaborations and promotional strategies that did not achieve expected financial growth.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations, encouraging affected shareholders to reach out to discuss their rights, demonstrating the firm's commitment to supporting investor rights.
See More
Class Action Lawsuit Filed Against Bath & Body Works, Inc.
- Lawsuit Background: Bath & Body Works, Inc. (NYSE: BBWI) is facing a class action lawsuit for alleged violations of federal securities laws, targeting the company and its officers on behalf of investors who purchased securities between June 4, 2024, and November 19, 2025.
- Allegations Details: The complaint alleges that throughout the class period, defendants made materially false and misleading statements while failing to disclose adverse facts about the company's business and prospects, misleading investors regarding its financial health.
- Financial Guidance Missteps: The lawsuit claims that the company's strategy of pursuing
See More
Class Action Notice for Bath & Body Works Securities
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the Class Period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm Advantages: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its successful track record and resource advantages, urging investors to select experienced legal counsel wisely.
- Investor Action Recommendations: Investors can visit Rosen Law Firm's website or call the toll-free number for more information on how to participate in the lawsuit, ensuring they have appropriate legal representation in the class action.
See More
Multiple Companies Face Class Action Lawsuits
- Varonis Systems Lawsuit: During the class period from February 4, 2025, to October 28, 2025, Varonis is accused of failing to sustain its annual recurring revenue growth, which has severely undermined investor confidence in the company's prospects, with a lead plaintiff deadline set for March 9, 2026.
- Ardent Health Allegations: Ardent Health faces accusations from July 18, 2024, to November 12, 2025, of inaccurately assessing the collectability of accounts receivable, leading to significant misrepresentation of its financial health, with investors required to act by March 9, 2026.
- CoreWeave Risk Disclosure: CoreWeave is alleged to have overstated its ability to meet customer demand during the period from March 28, 2025, to December 15, 2025, failing to adequately disclose the risks associated with reliance on a single third-party data center, which could materially impact revenue, with a lead plaintiff deadline of March 13, 2026.
- Bath & Body Works Financial Misrepresentation: Bath & Body Works is accused of failing to meet its financial guidance during the period from June 4, 2024, to November 19, 2025, with its brand collaboration strategy not effectively growing its customer base, requiring investor action by March 16, 2026.
See More
Class Action Filed Against Bath & Body Works for Securities Fraud
- Class Action Initiated: Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against Bath & Body Works, Inc., concerning investor losses from June 4, 2024, to November 19, 2025, highlighting serious issues regarding the company's financial transparency.
- Investor Loss Claims: The lawsuit seeks recovery of investment losses for affected investors under federal securities laws, indicating significant misstatements about the company's operations and prospects, which may lead to a decline in investor confidence.
- Financial Guidance Errors: The complaint alleges that Bath & Body Works failed to disclose that its strategy of pursuing “adjacencies, collaborations, and promotions” was not effectively growing its customer base, resulting in the company being unlikely to meet its previously issued financial guidance, potentially impacting future performance.
- Lead Plaintiff Process: Investors have until March 16, 2026, to apply to be appointed as lead plaintiffs in the class action, representing all affected investors in the litigation, underscoring the importance of legal processes in protecting investor rights.
See More
Faruqi & Faruqi Investigates Bath & Body Works for Securities Claims
- Legal Investigation Launched: Faruq & Faruq LLP is investigating Bath & Body Works for potential claims related to securities purchased between June 4, 2024, and November 19, 2025, which may affect investors' legal rights.
- Investor Contact Information: Affected investors are encouraged to contact Faruq & Faruq partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal options regarding the situation.
- Class Action Deadline: The firm reminds investors that March 16, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action filed against Bath & Body Works, emphasizing the importance of timely action.
- Potential Claim Risks: This investigation may lead to claims against Bath & Body Works, highlighting potential risks under securities law, which investors need to monitor closely to ensure their investment safety.
See More
Class Action Lawsuit Reminder Against Bath & Body Works, Inc.
- Class Action Notice: The Schall Law Firm reminds investors of a class action lawsuit against Bath & Body Works, Inc. (NYSE:BBWI) for violations of §§10(b) and 20(a) of the Securities Exchange Act, with a deadline for participation set for March 16, 2026.
- Investor Losses: Investors who purchased the company's securities between June 4, 2024, and November 19, 2025, suffered losses due to the company's false and misleading statements, indicating a failure to effectively grow its customer base and net sales.
- Market Reaction: As the market learned the truth about Bath & Body Works' financial situation, investors faced damages, reflecting the company's failure in brand collaborations and promotional strategies that did not achieve expected financial growth.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations, encouraging affected shareholders to reach out to discuss their rights, demonstrating the firm's commitment to supporting investor rights.
See More
